PETCT in the Staging of the Non-Small-Cell Lung Cancer

Abstract EN

Lung cancer is a common disease and the leading cause of cancer-related death in many countries.

Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis.

Positron emission tomography/computed tomography (PET/CT), combining anatomic information of CT and metabolic information of PET, is emerging as a potential diagnosis and staging test in patients with non-small-cell lung cancer (NSCLC).

The purpose of this paper is to discuss the value of integrated PET/CT in the staging of the non-small-cell lung cancer and its health economics.